ATryn (rEVO Bioloigics, Inc.)
Welcome to the PulseAid listing for the ATryn drug offered from rEVO Bioloigics, Inc.. This Recombinant Antithrombin [EPC],Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | rEVO Bioloigics, Inc. |
NON-PROPRIETARY NAME: | Antithrombin Recombinant |
SUBSTANCE NAME: | ANTITHROMBIN ALFA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Recombinant Antithrombin [EPC],Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2009-05-06 |
END MARKETING DATE: | 0000-00-00 |
ATryn HUMAN PRESCRIPTION DRUG Details:
Item Description | ATryn from rEVO Bioloigics, Inc. |
LABELER NAME: | rEVO Bioloigics, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 525([iU]/mL) |
START MARKETING DATE: | 2009-05-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42976-125_2c5e8a5c-7985-4cb8-9dbc-3bf646f9fe46 |
PRODUCT NDC: | 42976-125 |
APPLICATION NUMBER: | BLA125284 |
Other ANTITHROMBIN ALFA Pharmaceutical Manufacturers / Labelers: